Lack of new investments may undermine higher consumption
Reserve Bank of India (RBI) Governor Raghuram Rajan spoke on a host of issues at his last post-policy interaction with the media
There was buzz of Piyush Goyal being elevated to Cabinet rank but only Prakash Javadekar made the cut.
The regulator had issued alerts in June and July of 2015.
Popular antacid Mucaine Gel, manufactured by Pfizer's subsidiary Wyeth Laboratories, was also found laced with the heavy metals as well as cadmium.
The most worrisome aspect is that most water woes are the result of mismanagement
In 2013, Daiichi had launched the arbitration proceedings in Singapore.
Alkem Labs was issued drug alerts twice last year -- in June and July -- for its drug Glimekem.
The poor performance of capital goods - a bellwether for future growth - has alarmed most analysts
It accounted for over a third of foreign direct investment flows into India between 2000 and 2015
The draft bill allows euthanasia for patients who can take informed decisions; doctors to be protected from liability.
Daiichi alleged that Singh brothers had concealed and misrepresented critical information concerning US Food and Drug Administration and Department of Justice investigations into Ranbaxy
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
New data show tax reform, better tracking needed
NHAI to pull plug on Rs 3,000-crore ventures for poor show
Sanjeev Vashishta, chief executive officer at SRL Diagnostics, talks to Deepak Patel about expansion plans and regulations for the sector.
In most cases, they dodged bullets and, in some, recovered the same day
Govt bans brands with annual sales worth Rs 3,728 crore.
Between 2011 and 2014, they indirectly determined the price of tyres in the market, says report
Lobby group tells USTR it has got assurance from India on compulsory licensing.
